| 000 | 01507 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250512211449.0 | ||
| 264 | 0 | _c19840302 | |
| 008 | 198403s 0 0 eng d | ||
| 022 | _a0305-7372 | ||
| 024 | 7 |
_a10.1016/0305-7372(83)90024-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPrentice, H G | |
| 245 | 0 | 0 |
_aSequential studies on the role of mitoxantrone in the treatment of acute leukaemia. _h[electronic resource] |
| 260 |
_bCancer treatment reviews _cDec 1983 |
||
| 300 |
_a57-63 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnthraquinones _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDNA Repair _xdrug effects |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIntercalating Agents _xadverse effects |
| 650 | 0 | 4 |
_aLeukemia _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMitoxantrone |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 700 | 1 | _aRobbins, G | |
| 700 | 1 | _aMa, D D | |
| 700 | 1 | _aHo, A D | |
| 773 | 0 |
_tCancer treatment reviews _gvol. 10 Suppl B _gp. 57-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0305-7372(83)90024-5 _zAvailable from publisher's website |
| 999 |
_c6362795 _d6362795 |
||